Issue 14, 2020

Controlled drug release from polyelectrolyte–drug conjugate nanoparticles

Abstract

Encapsulating drugs in functional nanoparticles provides controlled and targeted release of drugs. In this study, a general approach for encapsulating hydrophobic drugs in polyelectrolyte nanoparticles was developed for a controlled drug release. Gemcitabine (GEM), an anticancer drug for pancreatic ductal adenocarcinoma (PDAC), was used as a model drug to produce poly(acrylic acid) (PAA)–GEM conjugate nanoparticles to achieve a controlled release of GEM in cells. The PAA–GEM conjugate nanoparticles were fabricated by coupling GEM onto PAA through the formation of amide bonds. The hydrophobic interactions of GEM molecules induced the formation of the nanoparticles with the GEM core and PAA shell. Fabrication conditions such as the PAA/GEM ratio and pH were optimized to achieve high structure stability and drug loading efficiency. The size and surface charge of the nanoparticles were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS) and zeta potential measurement. The optimized PAA–GEM nanoparticles had a size around 12 nm, 30 nm and 60 nm in dry state, water, and phosphate buffered saline (PBS), respectively. The encapsulation efficiency was 29.29 ± 1.7%, and the loading capacity was 9.44 ± 0.46%. Less than 7% GEM was released from the PAA–GEM nanoparticles after 96 hour incubation in phosphate buffered saline. The cytotoxic efficacy of the PAA–GEM nanoparticles in cancer cells was investigated through viability studies of PANC-1, a human pancreatic cancer cell line. It was found that the PAA–GEM nanoparticles had more than a 48 hour delay of releasing GEM and had the same cytotoxic efficacy in PANC-1 cells as free GEM. The uptake of the PAA–GEM nanoparticles by PANC-1 cells was investigated using PAA–GEM labeled by rhodamine G6. Fluorescence and bright field overlay images indicated that the PAA–GEM nanoparticles were taken up by PANC-1 cells within 2 hours. It is believed that the PAA–GEM nanoparticles were decomposed in PANC-1 cells and GEM was released from the nanoparticles.

Graphical abstract: Controlled drug release from polyelectrolyte–drug conjugate nanoparticles

Supplementary files

Article information

Article type
Paper
Submitted
02 Jan 2020
Accepted
06 Mar 2020
First published
07 Mar 2020

J. Mater. Chem. B, 2020,8, 2887-2894

Controlled drug release from polyelectrolyte–drug conjugate nanoparticles

R. Catarata, N. Azim, S. Bhattacharya and L. Zhai, J. Mater. Chem. B, 2020, 8, 2887 DOI: 10.1039/D0TB00012D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements